Acro Biomedical (ACBM) Share-based Compensation (2018 - 2021)

Acro Biomedical (ACBM) posted Share-based Compensation of $3.9 million for Q4 2021, up 34.59% on a QoQ basis from $2.9 million in Q3 2021.

Analysis

Acro Biomedical (ACBM) Share-based Compensation (2018 - 2021) Analysis & Trends

Acro Biomedical has reported Share-based Compensation for 3 years, with the latest figure at $3.9 million in Q4 2021.

On a quarterly basis, Share-based Compensation changed N/A year-over-year to $3.9 million in Q4 2021; TTM through Dec 2021 was $7.0 million, a N/A change from a year earlier, with the FY2021 full-year figure at $7.7 million, changed N/A from the prior year.
Share-based Compensation was $3.9 million for Q4 2021 at Acro Biomedical, up from $2.9 million in the prior quarter.
The five-year high for Share-based Compensation was $3.9 million in Q4 2021, with the low at $148395.0 in Q1 2019.
Average Share-based Compensation over 3 years is $1.2 million, with a median of $150044.5 recorded in 2018.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Share-based Compensation (Qtr)
1	Colgate Palmolive	70.27 Bn	68.90 Bn	3.30 Bn	38.00 Mn
2	Kenvue	34.17 Bn	33.06 Bn	2.30 Bn	56.00 Mn
3	Kimberly Clark	32.86 Bn	31.91 Bn	1.60 Bn	41.00 Mn
4	Bath & Body Works	3.85 Bn	3.05 Bn	692.00 Mn	-
5	Prestige Consumer Healthcare	2.32 Bn	2.26 Bn	-	-
6	Perrigo	1.99 Bn	1.59 Bn	313.90 Mn	6.80 Mn
7	Herbalife	1.32 Bn	946.20 Mn	1.03 Bn	29.40 Mn
8	Edgewell Personal Care	1.24 Bn	842.99 Mn	242.50 Mn	5.70 Mn
9	TFA Therapeutics	1.02 Bn	1.02 Bn	-	-
10	Acro Biomedical	1.80 Mn	1.80 Mn	-	-

Historic Data

Download Data